ArticleBMC cancer2023

Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment - oxaliplatin subscale: a prospective cohort study.

Zhancheng Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.